Your browser doesn't support javascript.
loading
Exome chip analyses in adult attention deficit hyperactivity disorder.
Zayats, T; Jacobsen, K K; Kleppe, R; Jacob, C P; Kittel-Schneider, S; Ribasés, M; Ramos-Quiroga, J A; Richarte, V; Casas, M; Mota, N R; Grevet, E H; Klein, M; Corominas, J; Bralten, J; Galesloot, T; Vasquez, A A; Herms, S; Forstner, A J; Larsson, H; Breen, G; Asherson, P; Gross-Lesch, S; Lesch, K P; Cichon, S; Gabrielsen, M B; Holmen, O L; Bau, C H D; Buitelaar, J; Kiemeney, L; Faraone, S V; Cormand, B; Franke, B; Reif, A; Haavik, J; Johansson, S.
Afiliação
  • Zayats T; K.G. Jebsen Centre for Neuropsychiatric Disorders, Department of Biomedicine, University of Bergen, Bergen, Norway.
  • Jacobsen KK; K.G. Jebsen Centre for Neuropsychiatric Disorders, Department of Biomedicine, University of Bergen, Bergen, Norway.
  • Kleppe R; K.G. Jebsen Centre for Neuropsychiatric Disorders, Department of Biomedicine, University of Bergen, Bergen, Norway.
  • Jacob CP; Section of Molecular Psychiatry, Clinical Research Unit on Disorders of Neurodevelopment and Cognition Center of Mental Health, University of Wuerburg, Würzburg, Germany.
  • Kittel-Schneider S; Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Ribasés M; Psychiatric Genetics Unit, Group of Psychiatry, Mental Health and Addictions, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Ramos-Quiroga JA; Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Richarte V; Biomedical Network Research Centre on Mental Health (CIBERSAM), Madrid, Spain.
  • Casas M; Psychiatric Genetics Unit, Group of Psychiatry, Mental Health and Addictions, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Mota NR; Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Grevet EH; Biomedical Network Research Centre on Mental Health (CIBERSAM), Madrid, Spain.
  • Klein M; Departments of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Corominas J; Psychiatric Genetics Unit, Group of Psychiatry, Mental Health and Addictions, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Bralten J; Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Galesloot T; Biomedical Network Research Centre on Mental Health (CIBERSAM), Madrid, Spain.
  • Vasquez AA; Departments of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Herms S; Psychiatric Genetics Unit, Group of Psychiatry, Mental Health and Addictions, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Forstner AJ; Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Larsson H; Biomedical Network Research Centre on Mental Health (CIBERSAM), Madrid, Spain.
  • Breen G; Departments of Psychiatry and Legal Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Asherson P; Department of Genetics, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
  • Gross-Lesch S; Department of Psychiatry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
  • Lesch KP; Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Cichon S; Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Gabrielsen MB; Department of Ophtalmology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Holmen OL; Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Bau CH; Department for Health Evidence, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Buitelaar J; Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Kiemeney L; Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Faraone SV; Department of Psychiatry, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Cormand B; Institute of Human Genetics, University of Bonn, Bonn, Germany.
  • Franke B; Department of Genomics, Life and Brain Center, Bonn, Germany.
  • Reif A; Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Haavik J; Institute of Human Genetics, University of Bonn, Bonn, Germany.
  • Johansson S; Department of Genomics, Life and Brain Center, Bonn, Germany.
Transl Psychiatry ; 6(10): e923, 2016 10 18.
Article em En | MEDLINE | ID: mdl-27754487
ABSTRACT
Attention-deficit/hyperactivity disorder (ADHD) is a highly heritable childhood-onset neuropsychiatric condition, often persisting into adulthood. The genetic architecture of ADHD, particularly in adults, is largely unknown. We performed an exome-wide scan of adult ADHD using the Illumina Human Exome Bead Chip, which interrogates over 250 000 common and rare variants. Participants were recruited by the International Multicenter persistent ADHD CollaboraTion (IMpACT). Statistical analyses were divided into 3

steps:

(1) gene-level analysis of rare variants (minor allele frequency (MAF)<1%); (2) single marker association tests of common variants (MAF⩾1%), with replication of the top signals; and (3) pathway analyses. In total, 9365 individuals (1846 cases and 7519 controls) were examined. Replication of the most associated common variants was attempted in 9847 individuals (2077 cases and 7770 controls) using fixed-effects inverse variance meta-analysis. With a Bonferroni-corrected significance level of 1.82E-06, our analyses of rare coding variants revealed four study-wide significant loci 6q22.1 locus (P=4.46E-08), where NT5DC1 and COL10A1 reside; the SEC23IP locus (P=6.47E-07); the PSD locus (P=7.58E-08) and ZCCHC4 locus (P=1.79E-06). No genome-wide significant association was observed among the common variants. The strongest signal was noted at rs9325032 in PPP2R2B (odds ratio=0.81, P=1.61E-05). Taken together, our data add to the growing evidence of general signal transduction molecules (NT5DC1, PSD, SEC23IP and ZCCHC4) having an important role in the etiology of ADHD. Although the biological implications of these findings need to be further explored, they highlight the possible role of cellular communication as a potential core component in the development of both adult and childhood forms of ADHD.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polimorfismo Genético / Transtorno do Deficit de Atenção com Hiperatividade / Análise de Sequência com Séries de Oligonucleotídeos / Sequenciamento do Exoma Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male Idioma: En Revista: Transl Psychiatry Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Noruega

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polimorfismo Genético / Transtorno do Deficit de Atenção com Hiperatividade / Análise de Sequência com Séries de Oligonucleotídeos / Sequenciamento do Exoma Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male Idioma: En Revista: Transl Psychiatry Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Noruega